• Explore /
  • Poster
  • / Days spent with healthcare contact by patients with metastatic castrate-resistant prostate cancer in the last year of life.

Days spent with healthcare contact by patients with metastatic castrate-resistant prostate cancer in the last year of life.

Abstract Poster

Authors

null

Daniel Sentana Lledo

Beth Israel Deaconess Medical Center, Boston, MA

Daniel Sentana Lledo , Amelia Barnett , David Johnson Einstein , Arjun Gupta , Alicia K. Morgans

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 100)

DOI

10.1200/JCO.2024.42.4_suppl.100

Abstract #

100

Poster Bd #

D15

Abstract Disclosures

Similar Posters

First Author: Siyuan S Guo

First Author: Tanya B. Dorff

Poster

2024 ASCO Genitourinary Cancers Symposium

Impact of race on outcomes to 177Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC).

Impact of race on outcomes to 177Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC).

First Author: Avina Rami

First Author: Ciara Conduit